Introduction
Interest in the p53 transcription factor is due to its large implication in human cancer (50%). Indeed, its function is altered or deleted in most types of cancers (Hollstein et al., 1991 (Hollstein et al., , 1994 Levine et al., 1991) .
This tumour suppressor has been called thè guardian of the genome' due to its role in signalling DNA repair or apoptosis to eliminate damaged cells (Lane, 1992) . Activation of the p53 protein is observed following stress situations, such as DNA damage (Levine, 1997) , oxidative stress (Renzing et al., 1996) , microtubule disrupting agents (Jimenez et al., 1999) , and hypoxia (Graeber et al., 1996) . Elevated p53 activity leads to cell cycle arrest or apoptosis, depending on the cell type and the intensity of the stimulus (Amundson et al., 1998; Levine, 1997) . Cell cycle arrest following p53 activation may occur at the G1/S or at the G2/M check points (Levine, 1997) .
Most of the p53 eects are due to its transcription factor activity, either by activation or by repression, of an increasing number of identi®ed target genes. This supposition is indirectly supported by the observation that nearly all mutations of the p53 gene in human tumours are within the DNA binding domain. The p53 DNA consensus sequence, 5'-PuPuPuC(A/T)(A/ T)GPyPyPy-3', was determined by El-Deiry et al. (1992) and Funk et al. (1992) . The number of upregulated p53 genes present in the human genome was evaluated by a p53 enhancer trap approach and is estimated to be 200 ± 300 (Tokino et al., 1994) . The present number of reported p53 genes is approximately 80. Therefore, there still exist a signi®cant number of p53 target genes not yet identi®ed.
Amongst the p53 response genes already analysed, there are those involved in cell cycle control, notably p21 (Waldman et al., 1995) , GADD45 (Zhan et al., 1999) , B99 (Utrera et al., 1998 ) and 14-3-3s (Hermeking et al., 1997) . In addition, there is an increasing number of p53 response genes associated with the apoptotic process. These include: BAX (Oltvai et al., 1993) , Fas (Owen-Schaub et al., 1995) , Dr5/KILLER (Wu et al., 1997) , PAG608 (Israeli et al., 1997) , IGFBp3 (Rajah et al., 1997) , and the PIGs . The insights provided by the identi®cation and characterization of p53 response genes have greatly advanced the p53 ®eld.
Using the Suppression Subtraction method (Diatchenko et al., 1996) to isolate cDNAs corresponding to dierentially expressed mRNAs, we isolated 17 cDNA fragments which correspond to mRNAs speci®cally induced upon wild type p53 expression and apoptosis in the EB-1 colon carcinoma cell line.
Among these genes are Ponsin SH3/P12/CAP/ FLAF2 (Mandai et al., 1999) , CDCrel2b/H5/PNUTL2 , APOBEC-2 (Liao et al., 1999) , IgG, cytokeratin 15 (Leube et al., 1988) , HGFL/MSP (Han and Degen, 1993) , Zap-70 (Chan et al., 1992) , lats2 (Yabuta et al., 2000) , PIG3 , and eight unknown genes. Amongst the unknown candidates there is one which shares signi®cant homology with chicken CTCF (Klenova et al., 1993) , a protein binding to insulator sequences and in so doing attenuates enhancer cross-talk between physically adjacent promoters (Bell et al., 1999) .
Results

Isolation of potential p53 regulated genes by suppression subtractive hybridization
Given the central role that p53 plays in human cancer, we were interested in isolating novel genes whose expression is under the control of wt p53. Clearly the identi®cation of p53 regulated genes such as p21 and BAX has been instrumental in comprehending the diverse aects of wt p53 expression. The EB-1 cell line is a stable transfectant of EB, a human colon carcinoma cell line, containing a metal inducible human wt p53 (Shaw et al., 1992) . The parental cell line, EB, is totally lacking in detectable p53 expression, either mutant or wt (Shaw et al., 1992) . The EB-1 cell line, when induced for wt expression, strongly upregulates p53 translational target genes such as p21 (Shaw et al., 1996) . Physiologically, EB-1 cells undergo apoptosis upon induction of wt p53 both in vitro and in vivo (Shaw et al., 1992) .
We used a Suppression Subtractive Hybridization technique (SSH) to select for mRNAs dierentially expressed between metal induced EB and EB-1, identifying potentially p53 regulated genes (Diatchenko et al., 1996) . Brie¯y, this technique employs suppression PCR (Siebert et al., 1995) in conjunction with subtractive hybridization to normalize the cDNA population and to enrich in cDNA fragments more abundantly present in a target population. Our target mRNA population is derived from EB-1 cells induced for wild type p53 expression and the driver being similarly induced EB mRNA. Synthetic p53 and p21mRNA were added to the driver population to minimize their presence in our candidate population. Surprisingly Bax, a reported p53 response gene (Miyashita and Reed, 1995) , is not upregulated in induced EB-1 cells (Shaw, data not shown) even though these cells undergo apoptosis following p53 induction (Shaw et al., 1992) .
The mRNA population was extracted from EB-1 cells induced with CdCl 2 for 8 h, a double stranded and linkered cDNA was synthesized and hybridized twice to a 30-fold excess of cDNA synthesized from mRNA of EB cells similarly induced to exclude metaldependent candidates. Eight hours of induction was chosen, since we had already established that maximum p53 mRNA expression is achieved 4 h after CdCl 2 induction and thus a greater likelihood of identifying primary transcription targets of wt p53.
Six-hundred-and-®fty-six candidate clones were obtained and subsequently analysed for their dierential expression between both conditions by hybridization to radio-labelled cDNA synthesized from induced EB and EB-1 mRNAs. Discarding p53 clones, and non dierentially expressed clones, we detected 27 dierentially expressed cDNA fragments of mRNA between EB-1 and EB induced situations. However, after sequencing, 17 unique cDNA candidates were retained as potential candidates for p53 regulated genes. GIP 2, for example, was present seven times within the original candidate population.
These candidate clones will be referred to GIPs (Genes Induced by P53). The number of independent isolates of particular GIPs is indicated in Table 1 . GIP-2, for example, was independently isolated seven times. The majority of the remaining GIPs had only single representatives in our initial selected population.
Northern analysis EB, EB-1 RNA
Northern analyses of all candidate clones with EB and EB-1 RNAs, uninduced and induced with CdCl 2 , are presented in Figure 1 . RNAs were prepared 12 h after induction, thus 8 h after maximal p53 mRNA expression (Shaw et al., 1992) . All 17 of the selected cDNAs correspond to mRNAs present at signi®cantly higher levels in RNA isolated from induced EB-1 cell line (Figure 1) . No candidates corresponding to metal induced genes were observed.
We have analysed relative mRNA accumulation for each GIP using multiple exposures and comparing relative intensities of response. This evaluation of the intensity of speci®c GIP mRNA induction allowed the distinction of high, medium and low expression levels following p53 induction. We thus classi®ed the GIPs as high: GIPs 1, 2, 4, 5, 7, 14, and 16; medium: GIPs 3, 9, 10, 11, 13, and 15 and low: GIPs 6, 8, 12, and 17 . Precise time course analysis of expression following p53 induction in EB-1 cells for GIPs 7, 15 and 16 (data not shown) con®rmed the idea that these assessments correspond to early, intermediate and late relative to GIP-11 (PIG 3) (Yu et al., 1999) .
Of additional note is the presence of multiple splice variants for GIP-2, GIP-4, GIP-5, GIP-8, GIP-9 and GIP-12. In the case of GIPs 4, 8, 9, and 10, there is an expressed mRNA of greater size present before wt p53 induction. Speci®c alternative splice variants of a p53 induced gene have already been reported (Collavin et al., 1999) . The potential interest of these splice variants will be discussed below.
Identification of candidate clones
Unigene cluster identi®cation, chromosomal localization (when known), mRNA size(s), protein homology and tissue expression of the individual GIPs are presented in Table 1 . The accession numbers of ESTs, which were sequenced for each relevant GIP, are also indicated in Table 1 . The tissue speci®city of expression of each GIP is indicated, either deduced from the source of ESTs within a Unigene cluster or by direct experimental determination by hybridization to a human Multiple tissue Northern (Clontech).
GIP-1 Does not belong to a Unigene cluster and has only a single homologous EST, thus all information pertaining to this clone was obtained by sequencing of the original isolated SSH clone (1.4 Kb), as well as by sequencing of 5' RACE clones. These two sources of sequence information were consistent, in predicting an ORF with reasonable homology (72%) to chicken CTCF and unveiled seven zinc ®ngers, when analysed by both the PROSITE and PFAM programs. In addition, a trapped exon sequence derived from within the critical region for the Cri du Chat syndrome on human chromosome 5 (Church et al., 1997) was identi®ed, when BLASTing this sequence against the GSS database. Tissue speci®city (Testis) for this clone was determined directly by hybridization to a human Multiple tissue Northern (Clontech), yielding a result which is consistent with the library source of the only homologous EST, namely testis (Table 1) .
GIP-2
This clone is neither homologous to a Unigene cluster nor any ESTs. Tissue speci®city was determined by hybridization to Multiple tissue Northern (Clontech) (Table 1) . No ORF is predicted from the sequence of the SSH fragment (361 nt). Multiple mRNAs of 1.7, 2.2, and 3 Kb are up-regulated following induction of p53 in EB-1 cells. Expression of this GIP is the strongest of all candidates analysed, consistent with the seven independent isolations of this clone.
GIP-3 Analysis of the sequence of a large insert EST clone (2 Kb) obtained from the Unigene cluster predicts an ORF which is neither signi®cantly homologous with any protein in the database nor contains any motif(s) recognized by the PROSITE program. Tissue speci®city of expression was deduced from the library source of the 48 ESTs within the Unigene cluster.
GIP-4
The sequence of the original SSH clone (326 nt), as well as sequence obtained from an EST (Image #2143129) within the Unigene cluster, was BLASTed against the HTGS and non redundant databases. This search uncovered extensive homology with a sequenced BAC clone (AL035541) at 20q13.3. The BAC sequence predicts a 199 aa ORF (CAB5555862.1) immediately 5' to the sequence we obtained with the EST clone. This ORF is predicted by both the FGENES and GENSCAN programs. The predicted ORF does not share homology with another GIP-5 Analysis of the sequence of the original SSH clone, as well as additional sequence obtained from IMAGE #1978918, listed within the Unigene cluster, predicts an ORF, but no signi®cant homologies nor motifs were uncovered by analysis.
GIP-6
This clone is identical to lats 2 (Yabuta et al., 2000) , a human homologue of a tumour suppressor gene originally isolated in Drosophila (Xu et al., 1995) . Lats 2 shares 68% identity with the Drosophila lats/ warts while lats 1 shares 60%. The two human lats homologues are 71% identical.
GIP-7 Analysis of the sequence of the original SSH clone (1.6 Kb) identi®ed a Unigene cluster, however, no protein homology was indicated from predicted ORF of the four partially sequenced ESTs comprising the cluster. A series of 5' RACEs yielded almost 6 Kb of the approximately 7.5 Kb mRNA, yet the predicted ORF of 130 aa does not exhibit homology with any known proteins. Table 1 . The position of migration of the 18S and 28S Ribosomal RNAs is indicated by arrows. The same membranes were hybridized with a probe for GAPDH to control for loading GIPs 10 ± 17 These candidates were readily identi®ed through BLASTing of the Unigene database with the sequence obtained from the isolated SSH fragments. The identi®ed genes for each of these clones is presented in Table 1 . Hereafter, reference will be made to the identi®ed gene and not the GIP indication. GIP-10 is CDCrel2b/H5/Pnutl2 (a septin family member most probably involved in cytokinesis) (Paavola et al., 1999) . GIP-11 is PIG3, a quinone oxidoreductase . GIP-12 is Ponsin/SH3/P12/ CAP/FLAF2 (Mandai et al., 1999; Ribon et al., 1998a) . GIP-13 is APOBEC-2, a cytosine deaminase mRNA editing protein (Liao et al., 1999) . GIP-14 is Cytokeratin 15 (Leube et al., 1988) . GIP-15 is Hepatocyte Growth Factor Like/Macrophage Stimulating Factor (HGFL/MSP) (Han and Degen, 1993) . GIP-16 is Zap-70 (Chan et al., 1992) . GIP-17 is homologous to IgH G3.
Northern analysis: wild type p53 containing cell lines treated or not with adriamycin
In an eort to con®rm p53 dependency of expression of the GIPs, we reasoned that alternative cell types should be investigated. It is well documented that wild type p53 is both stabilized and activated in cells following treatment with DNA damaging agents, such as adriamycin. We thus evaluated the expression of the GIPs in ®ve dierent human cell lines with an endogenous wild type p53, A549 (lung) (Noble et al., 1992) , HCT 116 (colon) (Take et al., 1996) , HepG2 (liver) (Hosono et al., 1991) , MCF7 (breast) (Bacus et al., 1996) , and TK6 (lymphoblastoid) (Xia and Liber, 1997), with or without adriamycin treatment. An additional cell line, LNZ308 (brain) (Trepel et al., 1998) , which has no detectable p53 expression, was included as a control (Figure 2 ). All blots were subsequently hybridized with a GAPDH probe to control for loading. None of the GIPs exhibit up regulation in all of the cell lines upon treatment with adriamycin, including PIG3, the quinone oxidoreductase (Polyak et al., 1997) .
p21 is the only gene analysed whose expression is upregulated in all ®ve treated cell lines (data not shown).
Eight of the 17 GIPs show p53 up-regulated expression, in at least one of the adriamycin treated cell lines. Up-regulation is observed for GIP-2, GIP-3, GIP-5, GIP-8, PIG3, Ponsin/SH3P12/CAP/FLAF2, cytokeratin 15, and HGFL/MSP.
Infection of the p53 negative LNZ308 (glioblastoma) and PC3 (prostate) cell lines with an adenovirus expressing wild type p53 under the control of the CMV promoter allowed the demonstration of p53 dependent expression of GIP 7 and ZAP 70 (data not shown), which were negative in all ®ve adriamycin treated cell lines. Thus, 10 of the original 17 candidates are expressed in a p53 dependent manner in at least two independent cellular situations.
Those GIPs, not exhibiting up-regulation in any of the ®ve cell lines examined, are GIPs 1, 4, lats 2, CDCrel2b/H5/Pnutl2, and APOBEC-2. Further examination in cell lines of other tissue origins, as well as examination of inducibility by wild type p53 adenovirus infection will be undertaken to further substantiate their retention as p53 response genes.
Discussion
We have presented evidence that GIPs are valid p53 response genes. Firstly, signi®cant and rapid upregulation upon metal induced expression of wt p53 in EB-1 cells is presented for all candidates. No induction of GIP expression is seen with the addition of metals to the parental cell line. The intensity of induction amongst the candidates is variable, yet readily demonstrable. Secondly, we were able to demonstrate that up-regulation of endogenous wild type p53 activity by adriamycin treatment resulted in corresponding up-regulation for seven of the 16 candidates, excluding PIG 3. Additionally, infection of p53 null cell lines with an adenovirus containing CMV-p53 allowed the demonstration of p53 dependent expression for GIP 7 and ZAP 70, negative in the adriamycin analysis. Furthermore, the presence of the quinone oxidoreductase (PIG 3) gene amongst our candidates is not proof, but is at least supportive of appropriate p53 response gene selection. The inability to demonstrate adriamycin induced upregulation for all GIPs is presumably not an indication of non p53 regulation, yet no doubt either cell type speci®city of p53 responsiveness or speci®-city of cytotoxic stress used. Most notably is GIP-1, which is negative for the ®ve cell lines examined with adriamycin. This candidate is uniquely expressed in the testes (Table 1) and therefore, the cell lines utilized for the adriamycin experiment may be inappropriate. Vogelstein and co-workers recently concluded that some p53 responsive genes exhibit cell type speci®c dependence on p53 due to a codependence on other transcription factors for expression (Yu et al., 1999) . Thus, in the case of GIP-1, cell lines of testicular origin may have been more appropriate to investigate p53 responsiveness of expression. Even independent cell lines of the same epithelial origin, colon, do not necessarily exhibit a consistent p53 target gene expression pro®le as shown by (Yu et al., 1999) .
Novel p53 response genes C Kostic and PH Shaw BAX gene expression is a good example of variability of response to an activated p53 (Thornborrow and Manfredi, 1999) . Bax is clearly a p53 response gene, yet not all cell types exhibit up-regulation of this gene upon 53 expression/activation (induced EB-1, for example).
The total number of up-regulated p53 response genes that has been predicted to exist in the human genome is from 200 ± 300 (Tokino et al., 1994) . At present the total number of reported p53 response genes, including the present report (16), is 93. It is worthwhile to list the overall types of genes which are regulated by p53. These include those involved in: DNA damage ± GADD45, and PA26; Angiogenesis ± thrombospondin 1, MMP-2 and BAI 1; Cytoskeleton ± B99, cytokeratin 8, Caveolin-1, and glypican; Apoptosis ± DR5/Killer, BAX, FAS, TRID, p22/ PGR1, SIAH-1, GML, FAS L and quinone oxidoreductase (PIG3); Signal transduction ± RGS14, and IGBP3; Growth ± EGF-R, TGFa, and TGFb; Cell cycle-p21, cyclin G, 14-3-3a, and BTG2; Zinc ®nger proteins ± HIC-1 and WIG1; and Dierentiation ± P2XM.
The p53 response genes identi®ed in the present report can be placed into the above categories as well. Below is a brief discussion of the biological function of each of the GIPs corresponding to either characterized proteins or which are signi®cantly homologous to characterized proteins, in the context of their being p53 regulated genes.
GIP-1
GIP-1 is homologous (59% identity ± 75% positives) to the factor CTCF (Klenova et al., 1993) , and constitutes the third zinc ®nger protein (PAG608/wig-1, and HIC-1, being the other two examples), whose expression is regulated by wild type p53. Chicken CTCF has recently been shown to bind insulator sequences (Bell et al., 1999) . In conjunction with other proteins, this binding results in physical attenuation of enhancer aects on adjacent promoters. (Bell et al., 1999) . It remains to be determined if the GIP-1 encoded protein is part of this protein complex. Additional sequence information obtained by 5' RACE extends the homology with CTCF and predicts an ORF with at least seven zinc ®ngers. The tissue speci®city of expression of GIP-1, testis, coincides with the known high levels of endogenous p53 activity in mice (Almon et al., 1993) and may re¯ect an important role for GIP-1 in testis developmental gene regulation. Figure 2 Northern analysis of GIP gene expression in cell lines containing an endogenous p53. 7,+refers to treatment or not with 0.2 mg/ml of adriamycin. The tissue origin of the presented cell lines are lymphoblastoid (TK6), breast (MCF7), lung (A549), and liver (HepG2). LNZ308 cells (brain) were used as a control, since they have no detectable expression. The same blots were hybridized with a GAPDH probe as in Figure 1 Oncogene Novel p53 response genes C Kostic and PH Shaw GIP-6 GIP-6 is lats 2, a human homologue of the tumour suppressor gene, lats/warts, originally isolated in Drosophila (Xu et al., 1995) . The strategy employed that identi®ed lats was to isolate recessive over proliferation mutants. Lats2 contains a protein kinase domain and a ubiquitin binding domain when examined by prosite. Very recently another human lats homologue, lats1, was analysed and shown to interact with CDC2 and inhibit its kinase activity, as well as its interaction with cyclin B (Tao et al., 1999) . Furthermore, knock-out mice of a mouse lats gene homologue display a typical tumour suppressor phenotype, namely soft tissue sarcomas, and ovarian stromal cell tumours . Obviously, the functional importance of the lats 2 homologue that we have identi®ed remains to be de®ned, yet it is enticing that the other lats homologue exhibits a tumour suppressor gene phenotype through its interaction with a cell cycle component, CDC2.
GIP-10
CDC rel2b/H5/PNUTL2 protein (GIP-10), is a member of the septin family, for which there are at present seven mammalian members. Originally described in yeast, both ®ssion and budding, Septin proteins have been shown to be involved not only in cytokinesis, but also in synaptic exocytosis (Beites et al., 1999) . This particular septin exhibits GTPmodulated binding to phospholipids including Phosphatidylinositol polyphosphate, PtdIns (4,5) P2 and (3,4,5) P3 . Furthermore, this septin protein was shown to associate with the cleavage furrow in mitotic cells, while in non-mitotic cells it associates with stress ®bres and the cortical actin network . The potential importance of this septin in the observed G2/M checkpoint that p53 possibly regulates is provocative.
GIP-12
The Ponsin/SH3P12/CAP/FLAF2 gene (GIP-12) encodes a protein belonging to the Ponsin/ArgBP2/ venexin family. All members of this family contain three SH3 (sarc homology 3 region) domains. It is through these SH3 domains that Ponsin protein interacts with Vinculin, an F-actin binding protein, at cell-cell and cell-matrix adherens junctions or with Afadin at Zonula adherens (Mandai et al., 1999) . In the role of an identical protein, CAP, it was demonstrated that the Ponsin/SH3P12/CAP/FLAF2 protein also directly interacts with the non-receptor focal adhesion tyrosine kinase p125 FAK (Ribon et al., 1998a) . Expression of Ponsin/SH3P12/CAP/FLAF2 in 3T3 ®broblasts induced formation of stress ®bres and focal adhesions. It is well documented that several alternatively spliced forms of Ponsin mRNA exist, however, the precise dierences in the encoded protein have not yet been determined. Interestingly, several Ponsin/SH3P12/CAP mRNA splice variants, are speci®cally up-regulated by p53 expression in EB-1 cells and adriamycin treatment of TK6 cells. In parallel ®ve dierent proteins are recognized with an antibody directed against the carboxy terminal region containing the SH3 domains (Ribon et al., 1998b) . It is provocative to imagine that these dierent proteins may have dierent physiological consequences (Mandai et al., 1999) . Loss of wild type p53 function in colon tumours coincide with migration of the tumour mass across the basement membrane. The loss of mobility constraints due to down-regulation of expression of a protein involved in cell-cell and cell-matrix attachments is at least consistent with the observed physiological events.
GIP-13
APOBEC-2 (GIP-13) is a member of a cytidine deaminase superfamily (Liao et al., 1999) . A closely related protein, APOBEC-1, functions in both mammalian and yeast cells as the catalytic subunit of an RNA editing complex whose best characterized substrate is the mRNA for apolipoprotein (apo) B (Maas et al., 1997) . The precise C?U editing activity results in a premature stop codon in this particular mRNA. An accessory protein of 65 Kd provides the template speci®city of APOBEC-1 (Mehta et al., 1996) . Although other mRNAs are thought to be targeted by APOBEC-1, this has not yet been demonstrated. APOBEC-2 does not display any apo B editing activity and thus its mRNA speci®city is to be determined.
GIP-14
Cytokeratin 15 (GIP-14) is a component of intermediate ®laments in strati®ed epithelia. A search of the human database identi®ed the sequence of a genomic clone (accession number AC0193499). Analysis of this sequence identi®ed two perfect p53 consensus sequences separated by 9 bp roughly 2.5 Kb upstream of the transcriptional start site. Although not proof of p53 regulation, it is an anticipated ®nding of a p53 response gene to contain such elements within close proximity to each other within the promoter region. Of note is that cytokeratin 8, as well, has been reported to be a p53 responsive gene (Mukhopadhyay and Roth, 1996) .
GIP-15
HGFL/MSP (Hepatocyte Growth Factor-like/Macrophage Simulating Factor (GIP-15) is strongly upregulated following induction of wild type p53 in EB-1 cells (Figure 1) . One role attributed to HGFL in concert with its receptor RON/STK is the induction of apoptosis (Iwama et al., 1996) in mouse erythroleukaemia cells (MEL/STK).
GIP-16
Zap-70 (GIP-16) was initially cloned and characterized as a protein interacting with an activated T cell receptor through SH2 domains and responsible for signal transduction. Ishijima et al. (1995) reported that Zap-70 mRNA, detected by Northern analysis, is expressed at lower but readily detectable levels in tissues other than spleen and thymus, most notably the brain (Ishijima et al., 1995) . Furthermore, in situ analysis revealed expression of Zap-70 mRNA in additional tissues, including bronchial epithelia, and intestinal epithelia, the latter cell type exhibiting expression uniquely in embryonic tissues. The receptor with which Zap-70 may be interacting in non-T cell tissues is unknown and therefore the biological signi®cance of p53 regulation in these tissues is at present unclear. One perfect p53 consensus surrounded by several half sites is present approximately 3 Kb upstream of the transcriptional start site (AC017099). Independent veri®cation of p53 binding to this site has not been performed.
GIP-17
The candidate clone GIP-17 is homologous with the constant region of IgG. The potential involvement of wild type p53 in the development of B cells, as well as playing a role in the expression of IgG has already been reported (Aloni-Grinstein et al., 1993; Shaulsky et al., 1991) . Obviously, the expression of this gene upon induction of wild type p53 in a colon tumour derived cell line, EB-1, is dicult to understand biologically.
Of additional note is the observation that induction of p53 up-regulates speci®c alternatively spliced mRNAs for GIPs 2, 8 and 9 and Ponsin/SH3P12/ CAP/FLAF2 (Figure 1) . Unfortunately, the biological function of the proteins encoded by the latter two mRNAs is not known and therefore any supposition of altered function by an altered ORF is speculative. The idea that wt p53 can in¯uence or change splicing variant representation of a speci®c mRNA has been reported previously (Collavin et al., 1999) . Additionally, Mdm2, PA26, and TP53TG1 all exhibit splicing variants following induction by p53.
The cytoskeleton is composed of three elements: microtubules, actin ®laments and intermediate ®la-ments, composed notably of cytokeratins. Treatment with a number of drugs aecting the integrity of the cytoskeleton, either at the level of microtubules (vinblastine, nocodazol, vincristine, colchicine and taxol Tishler et al. (1995) ), or at the level of actin ®bres (cytochalasin; Rubtsova et al. (1998) ), and heat shock (Li et al., 1999) ), results in a stabilized and activated p53. This type of observation prompted Wahl and colleagues in a recent review to hypothesize that p53 or a protein(s) upstream of p53 senses microtubule disarray (Jimenez et al., 1999) . We propose that this theme can be enlarged to include the status of actin ®bres as well. In further support of the latter idea are the observations that disruption of actin by either heat or cytochalasin treatment (Rubtsova et al., 1998 ) also activates and stabilizes p53 (Klotzsche et al., 1998) . In addition, it is noteworthy to list the proteins encoded by p53 regulated genes whose function is integral to the cytoskeletal architecture. This list includes actin (Comer et al., 1998) , B99 a microtubule-localized protein (Utrera et al., 1998) , the recently identi®ed p53 responsive caveolin-1 (Yu et al., 1999; Stahlhut and van Deurs, 2000) , cytokeratins 8 (Mukhopadhyay and Roth, 1996) and 15 (this study), Ponsin/SH3 P12/ CAP (this study), and CDCrel2b/H5/PNUTL2 (this study). In support of this proposition Gloushankova et al. (1997) reported that the disruption of actin bundles following mutant ras transformation of both ®bro-blasts and epitheliocytes was reversed by expression of wild type p53.
It is enticing to imagine that in addition to the role of p53 as a guardian of the genome, that it also`s urveys' the status of the cytoskeleton and reacts to disruptive treatments by transactivation of numerous genes whose encoded proteins are important components. If damage is too severe then apoptosis will proceed, as is often observed.
Materials and methods
Cell culture
EB, EB-1 (Shaw et al., 1992) , LNZ308 (Trepel et al., 1998) , A549 (Noble et al., 1992) , TK6 (Little et al., 1995) , HepG2 (Hosono et al., 1991) , HCT116 (Take et al., 1996) , MCF7 (Bacus et al., 1996) and PC3 (Arah et al., 1998) were cultured in Dulbecco's modi®ed Eagle medium (DMEM) (Life Technologies, Grand Island, New York, USA) supplemented with 10% heat inactivated foetal calf serum, 500 mg/ml Gentamycin and 0.25 mg/ml Fungizone in a humidi®ed incubator at 9% CO 2 . Treatment with adriamycin (0.2 mg/ ml) was for 18 h (Yu et al., 1999) . Recombinant adenovirus containing CMV-p53 and CMV-GFP expression modules were the kind gift of Roland Sahli (Institute of Microbiology, CHUV, Lausanne, Switzerland). Infection with adenoviruses (MOI: 3000) was for 1 h. RNA preparation was performed at 48 h for PC3 and LNZ308.
RNA, Northern analysis
Total RNA was extracted with guanidinium thiocyanatephenol-chloroform according to (Chomczynski and Saachi, 1987) . Poly(A)+ RNA was obtained by standard methods using oligo-dT cellulose chromatography (Sambrook et al., 1989) . Formaldehyde gels (Lehrach et al., 1977) were transferred to nylon membranes Machery-Nagel (DuÈ ren, Germany) and hybridized (Church and Gilbert, 1984) with random primer labelled probes (Feinberg and Vogelstein, 1984; Hodgson and Fisk, 1987) .
SSH technique
cDNA synthesis from Poly(A) + RNA was accomplished by Superscript II from Life Technologies (Grand Island, New York, USA) according to the manufacturer's suggestions. Second strand synthesis and RSA I digestion was according to standard procedures (Sambrook et al., 1989) . Addition of linkers and all other procedures relevant to the SSH technique were derived either from Diatchenko et al. (1999) or the supplier's recommendation (PCR-select cDNA subtraction, Clontech).
Sequence determination and analysis
All sequence determination were carried out on an ALFII express automated sequencer (Pharmacia). BLAST analysis (Altschul et al., 1990) with sequences obtained from the original cDNA clones was carried out using both non redundant and EST databases, as well as the Unigene cluster database (http://www.ch.embnet.org/software/aB-LAST.html). Most candidate clones (15/17) correspond to unique Unigene clusters (Table 1) . Within a Unigene cluster, depending on extent of information available, one can obtain the following information: (1) all ESTs belonging to the cluster with an indication of cDNA insert size for several of the largest, (2) available sequence information for each of the indicated ESTs, (3) eventual ORF homology or identity with a protein in the database and (4) chromosomal location. Additional sequence information of GIP clones was obtained by: (1) sequencing of ESTs indicated within a Unigene cluster (GIPs 3 ± 9), as having a cDNA insert corresponding to full length cDNA (knowing mRNA sizes from Northern analysis), (2) 5' RACE extension (GIP-1 and 7) and sequencing and (3) establishment of a sequence contig from available EST sequence in a Unigene cluster (GIP-6).
